Roles of exosomes in immunotherapy for solid cancers
C. Lyu(Chinese Academy of Medical Sciences & Peking Union Medical College), Qiming Wang(Hunan Cancer Hospital), Zhenqiang Sun(First Affiliated Hospital of Zhengzhou University), Haifeng Sun(First Affiliated Hospital of Zhengzhou University), Yang Liu(Zhengzhou University)
Cited by 106
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
|Cell Death Discovery|2024|145
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
|Cell Death and Disease|2023|130
Extracellular vesicles remodel tumor environment for cancer immunotherapy
|Molecular Cancer|2023|105